• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. ACTIVA; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR Back to Search Results
Model Number 37612
Device Problems Failure to Deliver Energy (1211); Delayed Charge Time (2586); Charging Problem (2892); Communication or Transmission Problem (2896)
Patient Problems Muscle Spasm(s) (1966); Neurological Deficit/Dysfunction (1982); Pain (1994); Therapeutic Response, Decreased (2271)
Event Date 04/25/2017
Event Type  Injury  
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
A health care provider (hcp) reported via a manufacturer representative that the patient was not able to charge the implantable neurostimulator (ins) more than 50 percent with continuous charging.The patient's dystonia had gotten worse and the ins battery was stinging pain at the back of it.The stinging pain worsened when the patient charged the ins, but it was there all of the time.The patient also had occasional jerks which are a sharper pain, that were not described as electric shocks.The hcp thought the ins needed replacing, but the ins had only been implanted for one year.The patient was currently hospitalized.The patient was implanted with a four lead system for deep brain stimulation (dbs).Impedances were checked on (b)(6) 2017 and they were measured to be within normal range.The ins battery was at 50 percent charged.The ins was programmed to c+, 1-, 2- at 1.3 v, 450 usec, and 125 hz on lead 1 of the left side, c+, 5-, 6- at 2.1 v, 450 usec, and 125 hz on the lead 2 of the left side, c+, 9-, 10- at 2.1v, 450 usec, a nd 125 hz on the lead 1 of the right side and 14-, 15+ at 2.1v, 300 usec, and 125 hz on lead 2 of the right side.The ins was checked again on (b)(6) 2017 and impedances were normal and the ins battery was at 25 percent charged.No changes had been made to the ins programming.No power on reset messages were displayed on the recharger and the patient did not have a patient programmer.The patient reported they had been charging the ins every day, but it was taking longer to charge.The patient had not noticed the ins symbol being off, but when the hcp checked the ins it was off.Since then, the patient had not been able to charge past 50 percent after charging for hours.The was scheduled for imaging on (b)(6) 2017.The hcp indicated there was a possibility that the ins would be replaced on (b)(6) 2017 due to the possibility of the ins being flipped.Recharge statistics showed that several recharging sessions were initiated on (b)(6) 2017.The ins was not charging and there was zero average coupling.No further patient complications were reported.The patient's indication for use is dystonia.
 
Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received from a manufacturer representative reported the implantable neurostimulator (ins) was found not to be flipped.A revision was done and the ins was explanted and replaced.
 
Manufacturer Narrative
Analysis identified that the implantable neurostimulator (ins) is functioning within specifications but has reduced capacity due to overdischarge.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Analysis results were not available at the time of this report.A follow-up report will be sent when analysis is completed.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACTIVA
Type of Device
STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINSONIAN TREMOR
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer (Section G)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
minneapolis, MN 55432
7635263920
MDR Report Key6571758
MDR Text Key75323988
Report Number3004209178-2017-10440
Device Sequence Number1
Product Code MRU
Combination Product (y/n)N
Reporter Country CodeUK
PMA/PMN Number
H020007
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 01/31/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/14/2016
Device Model Number37612
Device Catalogue Number37612
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/30/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 04/26/2017
Initial Date FDA Received05/17/2017
Supplement Dates Manufacturer ReceivedNot provided
11/30/2017
01/05/2018
Supplement Dates FDA Received05/18/2017
12/06/2017
01/31/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/27/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-